Prediction: U.S. Options Volume Will Set a Record for the Seventh Straight Year

U.S. options volume is trending toward a 7th straight record year, with the past year’s single-day high exceeding 110M contracts and 2026 averaging nearly 71M/day vs ~61M/day in 2025. Cboe reported Q2’26 net revenue of $732M (+25% YoY) and derivatives net revenue of $413M (+30% YoY), with average daily index options volume up 32% to 6.2M. Nasdaq posted $1.5B net revenue (+15% YoY) as index options revenue more than doubled for the fourth straight quarter, supported by index ETP assets crossing $1T; both exchanges are also launching longer-hours and new event/prediction option products.

Analysis

The main market implication is not just higher volumes, but higher-quality revenue mix: exchange fees from index/options activity are structurally more incremental-margin than cash equity volume. CBOE is the cleaner beneficiary because its P&L is more levered to derivatives and less burdened by slower-moving legacy franchises; NDAQ participates, but the upside is diluted by its broader business mix.

The second-order risk is that the current run-rate may be partially regime-driven rather than purely secular. A normalization in realized volatility, a lull in macro/event dispersion, or a cooling of retail short-dated activity could flatten growth within 1-2 quarters even if the structural trend stays intact over 6-18 months. Longer trading hours are likely a net positive for participation, but the first-order effect may be volume migration across time buckets rather than fully additive demand, while compliance and technology costs rise before monetization does.

The contrarian miss is that the market may be overpaying for 'all options growth is permanent.' Record volumes can coexist with limited economic moats if fee pressure, product commoditization, or regulatory scrutiny on speculative structures intensifies. The new product slate is promising, but the KPI/event-contract initiatives should be treated as option value, not earnings power, until regulators and liquidity providers prove they can create durable depth.

Key Decisions for Investors

• Long CBOE / short NDAQ for 1-3 months: CBOE is the higher-beta pure play on options growth; the pair should work if index/options ADV stays elevated and earnings revisions remain upward. Falsify if CBOE derivatives revenue growth drops back below the mid-teens while NDAQ's market services stays stable.
• Accumulate CBOE on pullbacks or via a 3-6 month call spread: best risk/reward if management converts volume momentum into guidance. Avoid chasing after spikes; the edge is in owning the cleaner earnings lever, not the headline.
• If you want lower-beta exposure, prefer NDAQ only as a 'safer' derivative proxy, but expect less multiple expansion than CBOE. Falsify if the upcoming event-options launch plus 23/5 trading produces a visible step-up in options take-rate over two quarters.
• Do not underwrite the prediction-market/KPI products into base case valuation yet; treat them as an alert/watch item pending regulatory approval and actual liquidity. If approved, revisit as a long-dated optionality trade rather than a core earnings thesis.